Literature DB >> 9106365

Potential virulence factors of Proteus bacilli.

A Rózalski1, Z Sidorczyk, K Kotełko.   

Abstract

The object of this review is the genus Proteus, which contains bacteria considered now to belong to the opportunistic pathogens. Widely distributed in nature (in soil, water, and sewage), Proteus species play a significant ecological role. When present in the niches of higher macroorganisms, these species are able to evoke pathological events in different regions of the human body. The invaders (Proteus mirabilis, P. vulgaris, and P. penneri) have numerous factors including fimbriae, flagella, outer membrane proteins, lipopolysaccharide, capsule antigen, urease, immunoglobulin A proteases, hemolysins, amino acid deaminases, and, finally, the most characteristic attribute of Proteus, swarming growth, enabling them to colonize and survive in higher organisms. All these features and factors are described and commented on in detail. The questions important for future investigation of these facultatively pathogenic microorganisms are also discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106365      PMCID: PMC232601          DOI: 10.1128/mmbr.61.1.65-89.1997

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  265 in total

Review 1.  Cell adhesion and invasion mechanisms in microbial pathogenesis.

Authors:  B B Finlay
Journal:  Curr Opin Cell Biol       Date:  1990-10       Impact factor: 8.382

2.  The structure of Proteus penneri strain 14-O-specific polysaccharide containing D- and L-alanine.

Authors:  E V Vinogradov; A S Shashkov; Y A Knirel; N K Kochetkov; Z Sidorczyk; A Swierzko
Journal:  Carbohydr Res       Date:  1991-10-14       Impact factor: 2.104

3.  Differentiation of Serratia marcescens 274 into swimmer and swarmer cells.

Authors:  L Alberti; R M Harshey
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

Review 4.  Urinary calculi: microbiological and crystallographic studies.

Authors:  I J Rosenstein
Journal:  Crit Rev Clin Lab Sci       Date:  1986       Impact factor: 6.250

5.  Binding of polymyxin B nonapeptide to gram-negative bacteria.

Authors:  M Vaara; P Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  Identification and typing of Proteus penneri and Proteus vulgaris biogroups 2 and 3, from clinical sources, by computerized analysis of electrophoretic protein patterns.

Authors:  M Costas; B Holmes; K A Frith; C Riddle; P M Hawkey
Journal:  J Appl Bacteriol       Date:  1993-11

7.  The effect of protein and urine on uropathogen adhesion to polymer substrata.

Authors:  L Hawthorn; G Reid
Journal:  J Biomed Mater Res       Date:  1990-10

8.  Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells.

Authors:  R R Isberg; D L Voorhis; S Falkow
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

9.  Pore-forming activity of OmpA protein of Escherichia coli.

Authors:  E Sugawara; H Nikaido
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

10.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more
  64 in total

1.  Emerging extended-spectrum beta-lactamases in Proteus mirabilis.

Authors:  Laura Pagani; Roberta Migliavacca; Lucia Pallecchi; Cecilia Matti; Ernesto Giacobone; Gianfranco Amicosante; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Molecular and genetic analyses of the putative Proteus O antigen gene locus.

Authors:  Quan Wang; Agnieszka Torzewska; Xiaojuan Ruan; Xiaoting Wang; Antoni Rozalski; Zhujun Shao; Xi Guo; Haijian Zhou; Lu Feng; Lei Wang
Journal:  Appl Environ Microbiol       Date:  2010-06-25       Impact factor: 4.792

3.  Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea.

Authors:  Wonkeun Song; Juwon Kim; Il Kwon Bae; Seok Hoon Jeong; Young Hee Seo; Jong Hee Shin; Sook Jin Jang; Young Uh; Jeong Hwan Shin; Mi-Kyung Lee; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugR.

Authors:  Nadia Liassine; Stéphanie Madec; Béatrice Ninet; Catherine Metral; Martine Fouchereau-Peron; Roger Labia; Raymond Auckenthaler
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.

Authors:  L M Weigel; G J Anderson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Activity of Proteus mirabilis FliL is viscosity dependent and requires extragenic DNA.

Authors:  Yi-Ying Lee; Julius Patellis; Robert Belas
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase.

Authors:  Noriyuki Nagano; Naohiro Shibata; Yuko Saitou; Yukiko Nagano; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Serological and structural characterization of the O-antigens of the unclassified Proteus mirabilis strains TG 83, TG 319, and CCUG 10700 (OA).

Authors:  Agnieszka Zabłotni; Krystyna Zych; Anna N Kondakova; Małgorzata Siwińska; Yuriy A Knirel; Zygmunt Sidorczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

10.  ECA-immunogenicity of Proteus mirabilis strains.

Authors:  Katarzyna Anna Duda; Katarzyna Teresa Duda; Agnieszka Beczała; Katarzyna Kasperkiewicz; Joanna Radziejewska-Lebrecht; Mikael Skurnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-03-31       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.